KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to $4.4 million.

  • Precigen's Share-based Compensation rose 11290.64% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 3044.65%. This contributed to the annual value of $9.5 million for FY2024, which is 421.72% down from last year.
  • Per Precigen's latest filing, its Share-based Compensation stood at $4.4 million for Q3 2025, which was up 11290.64% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Precigen's Share-based Compensation registered a high of $5.4 million during Q1 2021, and its lowest value of $1.6 million during Q2 2025.
  • Moreover, its 5-year median value for Share-based Compensation was $2.4 million (2021), whereas its average is $2.7 million.
  • As far as peak fluctuations go, Precigen's Share-based Compensation tumbled by 4586.96% in 2021, and later soared by 11290.64% in 2025.
  • Over the past 5 years, Precigen's Share-based Compensation (Quarter) stood at $2.4 million in 2021, then decreased by 9.5% to $2.2 million in 2022, then increased by 2.35% to $2.3 million in 2023, then rose by 26.66% to $2.9 million in 2024, then surged by 53.16% to $4.4 million in 2025.
  • Its Share-based Compensation was $4.4 million in Q3 2025, compared to $1.6 million in Q2 2025 and $2.7 million in Q1 2025.